Related Experiment Video
Updated: Jan 30, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
The AAA+ ATPase/ubiquitin ligase mysterin stabilizes cytoplasmic lipid droplets
Munechika Sugihara1, Daisuke Morito2,3, Shiori Ainuki1
1Faculty of Life Sciences, Kyoto Sangyo University, Kyoto, Japan.
Abstract:
Mysterin, also known as RNF213, is an intracellular protein that forms large toroidal oligomers. Mysterin was originally identified in genetic studies of moyamoya disease (MMD), a rare cerebrovascular disorder of unknown etiology. While mysterin is known to exert ubiquitin ligase and putative mechanical ATPase activities with a RING finger domain and two adjacent AAA+ modules, its biological role is poorly understood. Here, we report that mysterin is targeted to lipid droplets (LDs), ubiquitous organelles specialized for neutral lipid storage, and markedly increases their abundance in cells. This effect was exerted primarily through specific elimination of adipose triglyceride lipase (ATGL) from LDs. The ubiquitin ligase and ATPase activities of mysterin were both important for its proper LD targeting. Notably, MMD-related mutations in the ubiquitin ligase domain of mysterin significantly impaired its fat-stabilizing activity. Our findings identify a unique new regulator of cytoplasmic LDs and suggest a potential link between the pathogenesis of MMD and fat metabolism.
Insights
Mysterin (RNF213) protein regulates lipid droplets (LDs) by eliminating adipose triglyceride lipase (ATGL). MMD-related mutations impair this fat-stabilizing activity, linking moyamoya disease to fat metabolism.
Area of Science:
- Biochemistry
- Cell Biology
- Genetics
Background:
- Mysterin (RNF213) is an intracellular protein linked to moyamoya disease (MMD).
- Its biological functions, despite known ubiquitin ligase and ATPase activities, remain unclear.
- Lipid droplets (LDs) are organelles central to neutral lipid storage.
Purpose of the Study:
- To investigate the biological role of mysterin (RNF213).
- To determine mysterin's effect on lipid droplet (LD) abundance and regulation.
- To explore the connection between MMD pathogenesis and fat metabolism.
Main Methods:
- Cellular localization studies to determine mysterin's target organelles.
- Biochemical assays to assess mysterin's enzymatic activities and interactions.
- Analysis of MMD-related mutations in mysterin's functional domains.
Main Results:
- Mysterin (RNF213) is targeted to lipid droplets (LDs), significantly increasing their abundance.
- Mysterin promotes LD accumulation by eliminating adipose triglyceride lipase (ATGL) from LDs.
- Both ubiquitin ligase and ATPase activities are crucial for mysterin's LD targeting and fat-stabilizing function.
- MMD-associated mutations in the ubiquitin ligase domain impair mysterin's ability to stabilize LDs.
Conclusions:
- Mysterin (RNF213) is identified as a novel regulator of cytoplasmic lipid droplets (LDs).
- The findings suggest a potential link between moyamoya disease (MMD) pathogenesis and cellular fat metabolism.
- Mysterin's role in LD regulation offers new insights into MMD etiology.
Related Concept Videos
Cytoplasm
Protein Folding and Misfolding
The cytoplasm is the location for several cellular processes, including protein synthesis and folding. The aqueous nature of the cytosol promotes protein folding such that the hydrophobic amino acid side chains are buried in the protein...
Cytoplasm
Protein Folding and Misfolding
The cytoplasm is the location for several cellular processes, including protein synthesis and folding. The aqueous nature of the cytosol promotes protein folding such that the hydrophobic amino acid side chains are buried in the protein...
RNA Stability
Lipid Digestion
What are Lipids?
Nuclear Stability
To hold positively charged protons together...

